Stay updated on Semaglutide Once-Daily Tablets in Overweight Clinical Trial
Sign up to get notified when there's something new on the Semaglutide Once-Daily Tablets in Overweight Clinical Trial page.

Latest updates to the Semaglutide Once-Daily Tablets in Overweight Clinical Trial page
- Check2 days agoChange DetectedA new revision entry v3.5.3 has been added to the study's record history, indicating the latest update. The previous revision v3.5.2 was removed from the visible history.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRevision history updated to include v3.5.2 and remove v3.5.0.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check45 days agoChange DetectedRevision history updated: added v3.5.0 and removed v3.4.3 in the Record History.SummaryDifference0.1%

- Check52 days agoChange DetectedRevision history updated: added v3.4.3 and removed v3.4.2.SummaryDifference0.1%

- Check80 days agoChange DetectedLatest revision on 2026-02-05 (v3.4.2) adds Returned date, Quality Control Review Has Not Concluded, and new study sections such as Adverse Events, Outcome Measures (Results), Baseline Characteristics, and Participant Flow. It also removes the older government funding notice and the prior revision (v3.4.1).SummaryDifference2%

- Check87 days agoChange DetectedA government funding notice banner was added and the revision label updated to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

Stay in the know with updates to Semaglutide Once-Daily Tablets in Overweight Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide Once-Daily Tablets in Overweight Clinical Trial page.